Filana Therapeutics, Inc. (FLNA)
0.93
-0.03
(-3.23%)
USD |
NASDAQ |
Aug 24, 16:00
0.9356
+0.01
(+0.60%)
After-Hours: 07:29
Filana Therapeutics Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.0006 |
| September 30, 2022 | 0.0008 |
| June 30, 2022 | 0.0009 |
| March 31, 2022 | 0.0009 |
| December 31, 2021 | 0.0009 |
| September 30, 2021 | 0.001 |
| June 30, 2021 | 0.001 |
| March 31, 2021 | 0.0011 |
| December 31, 2020 | 0.0032 |
| September 30, 2020 | 0.0132 |
| June 30, 2020 | 0.0019 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0027 |
| December 31, 2019 | 0.0041 |
| September 30, 2019 | 0.0065 |
| June 30, 2019 | 0.0076 |
| March 31, 2019 | 0.0085 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| CorMedix, Inc. | 0.315 |
| Eloxx Pharmaceuticals, Inc. | 0.00 |
| Cannabis Global, Inc. | -- |
| Breakthrough Chemistry, Inc. | 0.2335 |
| BioStem Technologies, Inc. | 0.0443 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 103.90M |
| Total Liabilities (Quarterly) | 40.29M |
| Shareholders Equity (Quarterly) | 63.61M |
| Current Ratio | 2.085 |